<DOC>
	<DOCNO>NCT01883492</DOCNO>
	<brief_summary>The primary objective clinical study include : - Evaluate E1 Wear include early bedding-in process , clinical outcome patient receive Total Hip Arthroplasty E1 - Compare E1 wear use CoCr Biolox Delta head</brief_summary>
	<brief_title>A Prospective Multi-center Study Total Hip Arthroplasty With E1</brief_title>
	<detailed_description>This study design PROSPECTIVE , RANDOMIZED , MULTI-CENTER Study compare two different material ( CoCr Delta ceramic ) articulate E1 Highly Crosslinked polyethylene Hip Replacement . Patient population 160 ( 80 ) . Follow-up period 10 year postoperatively . E1 liners thickness 4.8mm 45 degree position ( load bearing direction ) use case . Randomization occur via random number generator 4 block randomization .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<criteria>Osteoarthritis Age 20 75 time operation Patients limited comorbidity ASA IIII Patients must able understand instruction willing return follow In accordance approve Absolute Relative Contraindications use participate country E1 liner Delta Ceramic CoCr femoral head hip system System . Absolute contraindication include : infection , sepsis , osteomyelitis . Relative contraindication include : 1. uncooperative patient patient neurologic disorder incapable follow direction , 2. osteoporosis , 3. metabolic disorder may impair bone formation , 4. osteomalacia , 5. distant focus infection may spread implant site , 6. rapid joint destruction , mark bone loss bone resorption apparent roentgenogram , 7. vascular insufficiency , muscular atrophy , neuromuscular disease . 8. pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Only Female</keyword>
	<keyword>Age 20 - 75 time operation</keyword>
</DOC>